Exagen Inc. (XGN) Tops Q1 EPS by 24c

Exagen Inc. (NASDAQ: XGN) reported Q1 EPS of ($0.44), $0.24 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.4 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Downgrades Kongsberg Gruppen ASA (KOG:NO) to Underweight
• Morgan Stanley Upgrades KION Group AG (KGX:GR) (KIGRY) to Overweight